Cystatin C versus creatinine in determining risk based on kidney function

MG Shlipak; K. Matsushita; J Arnlov; LA Inker; R Katz; KR Polkinghorne; D. Rothenbacher; MJ Sarnak; B.C. Astor; J. Coresh; A.S. Levey; [No Value] CKD Prognosis Consortium; P.J. Blankestijn; A.D. van Zuilen; R.T. Gansevoort

doi:10.1056/NEJMoa1214234.

Cystatin C versus creatinine in determining risk based on kidney function

Translated title of the contribution: Cystatin C versus creatinine in determining risk based on kidney function

MG Shlipak, K. Matsushita, J Arnlov, LA Inker, R Katz, KR Polkinghorne, D. Rothenbacher, MJ Sarnak, B.C. Astor, J. Coresh, A.S. Levey, [No Value] CKD Prognosis Consortium, P.J. Blankestijn, A.D. van Zuilen, R.T. Gansevoort

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Cystatin C versus creatinine in determining risk based on kidney function
Original language	Undefined/Unknown
Pages (from-to)	932-943
Number of pages	12
Journal	New England Journal of Medicine
Volume	369
Issue number	10
DOIs	https://doi.org/10.1056/NEJMoa1214234.
Publication status	Published - 2013

Access to Document

10.1056/NEJMoa1214234.

http://www.ncbi.nlm.nih.gov/pubmed/?term=24004120

Cite this

Shlipak, MG., Matsushita, K., Arnlov, J., Inker, LA., Katz, R., Polkinghorne, KR., Rothenbacher, D., Sarnak, MJ., Astor, B. C., Coresh, J., Levey, A. S., CKD Prognosis Consortium, N. V., Blankestijn, P. J., van Zuilen, A. D., & Gansevoort, R. T. (2013). Cystatin C versus creatinine in determining risk based on kidney function. New England Journal of Medicine, 369(10), 932-943. https://doi.org/10.1056/NEJMoa1214234.

@article{a58ab62d22aa4846b4c8262e1e16a915,

title = "Cystatin C versus creatinine in determining risk based on kidney function",

author = "MG Shlipak and K. Matsushita and J Arnlov and LA Inker and R Katz and KR Polkinghorne and D. Rothenbacher and MJ Sarnak and B.C. Astor and J. Coresh and A.S. Levey and {CKD Prognosis Consortium}, {[No Value]} and P.J. Blankestijn and {van Zuilen}, A.D. and R.T. Gansevoort",

year = "2013",

doi = "10.1056/NEJMoa1214234.",

language = "Undefined/Unknown",

volume = "369",

pages = "932--943",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

Shlipak, MG, Matsushita, K, Arnlov, J, Inker, LA, Katz, R, Polkinghorne, KR, Rothenbacher, D, Sarnak, MJ, Astor, BC, Coresh, J, Levey, AS, CKD Prognosis Consortium, NV, Blankestijn, PJ, van Zuilen, AD & Gansevoort, RT 2013, 'Cystatin C versus creatinine in determining risk based on kidney function', New England Journal of Medicine, vol. 369, no. 10, pp. 932-943. https://doi.org/10.1056/NEJMoa1214234.

TY - JOUR

T1 - Cystatin C versus creatinine in determining risk based on kidney function

AU - Shlipak, MG

AU - Matsushita, K.

AU - Arnlov, J

AU - Inker, LA

AU - Katz, R

AU - Polkinghorne, KR

AU - Rothenbacher, D.

AU - Sarnak, MJ

AU - Astor, B.C.

AU - Coresh, J.

AU - Levey, A.S.

AU - CKD Prognosis Consortium, [No Value]

AU - Blankestijn, P.J.

AU - van Zuilen, A.D.

AU - Gansevoort, R.T.

PY - 2013

Y1 - 2013

U2 - 10.1056/NEJMoa1214234.

DO - 10.1056/NEJMoa1214234.

M3 - Article

SN - 0028-4793

VL - 369

SP - 932

EP - 943

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -